£4m dedicated to advancing the development and application of non-animal technologies, such as bioprinting human tissue
Owner/Developer: National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)
Fifteen business collaborations, carrying out early-stage investigations into the feasibility of novel non-animal technologies, have received support from five key funding bodies, including the NC3Rs.
The development of non-animal technologies is vital in the search for alternatives that can replace the use of animals in scientific research. Fifteen feasibility studies, carried out by collaborations between companies and academia, will look at a range of non-animal technologies. The technologies capitalise upon recent advances in the biosciences and engineering including; induced pluripotent stem cells, tissue engineering technologies, high-throughput platforms, computational modelling, novel imaging techniques and bioprinting technologies.
The NC3Rs, the UK’s innovation agency, the Technology Strategy Board, the Biotechnology and Biological Sciences Research Council, the Defence Science and Technology Laboratory and the Engineering and Physical Sciences Research Council have joined forces to fund the business-led projects which have the potential to change both the drug development and chemical testing landscape.
|Audience:||Scientists - Regulators - Industry - Researchers|
|User access:||Open access|
|Updating frequency:||08 July 2014|
|Relevance:||Replacement - Reduction|
|Purpose:||Documentation and information - Method development|
|Technology/Tools:||3D printing - Tissue engineering|
Fant du det du lette etter?Ja, jeg fant det! Nei, jeg fant det ikke!
Takk for din tilbakemelding! Vær oppmerksom på at vi ikke kan kontakte deg hvis ikke du oppgir din epostadresse.
Hva lette du etter?
Gi oss gjerne en tilbakemelding slik at vi kan forbedre informasjonen på siden. På forhånd takk for hjelpen! Vennligst skriv inn din epostadresse hvis du vil ha et svar.Kontakt oss gjerne på e-post hvis du har spørsmål.